Machine learning-based radiomics analysis in predicting RAS mutational status using magnetic resonance imaging-Reference-Cited by-同舟云学术

Machine learning-based radiomics analysis in predicting RAS mutational status using magnetic resonance imaging

Published:2024-02-02 Issue: Volume: Page:
ISSN:1826-6983
Container-title:La radiologia medica
language:en
Short-container-title:Radiol med

Author:

Granata Vincenza^ORCID,Fusco Roberta,Brunese Maria Chiara,Di Mauro Annabella,Avallone Antonio,Ottaiano Alessandro,Izzo Francesco,Normanno Nicola,Petrillo Antonella

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11547-024-01779-x.pdf

Reference38 articles.

1. Ottaiano A, Scala S, Santorsola M, Trotta AM, D’Alterio C, Portella L, Clemente O, Nappi A, Zanaletti N, De Stefano A, Avallone A, Granata V, Notariello C, Luce A, Lombardi A, Picone C, Petrillo A, Perri F, Tatangelo F, Di Mauro A, Albino V, Izzo F, Rega D, Pace U, Di Marzo M, Chiodini P, De Feo G, Del Prete P, Botti G, Delrio P, Caraglia M, Nasti G (2021) Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol. Ther Adv Med Oncol 24(13):1758835921989223. https://doi.org/10.1177/1758835921989223

2. Ottaiano A, Caraglia M, Di Mauro A, Botti G, Lombardi A, Galon J, Luce A, D’Amore L, Perri F, Santorsola M, Hermitte F, Savarese G, Tatangelo F, Granata V, Izzo F, Belli A, Scala S, Delrio P, Circelli L, Nasti G (2020) Evolution of mutational landscape and tumor immune-microenvironment in liver oligo-metastatic colorectal cancer. Cancers (Basel) 12(10):3073. https://doi.org/10.3390/cancers12103073

3. Cervantes A, Adam R, Roselló S, Arnold D, Normanno N, Taïeb J, Seligmann J, De Baere T, Osterlund P, Yoshino T, Martinelli E (2023) ESMO guidelines committee. Electronic address: clinicalguidelines@esmo.org. metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 34(1):10–32. https://doi.org/10.1016/j.annonc.2022.10.003

4. Mateo J, Steuten L, Aftimos P, André F, Davies M, Garralda E, Geissler J, Husereau D, Martinez-Lopez I, Normanno N, Reis-Filho JS, Stefani S, Thomas DM, Westphalen CB, Voest E (2022) Delivering precision oncology to patients with cancer. Nat Med 28(4):658–665. https://doi.org/10.1038/s41591-022-01717-2

5. Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP, Normanno N, Scarpa A, Robson M, Meric-Bernstam F, Wagle N, Stenzinger A, Bonastre J, Bayle A, Michiels S, Bièche I, Rouleau E, Jezdic S, Douillard JY, Reis-Filho JS, Dienstmann R, André F (2020) Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO precision medicine working group. Ann Oncol 31(11):1491–1505. https://doi.org/10.1016/j.annonc.2020.07.014